ReviewThe oncologist2026

Immune checkpoint inhibitors in resectable and locoregionally advanced HNSCC: past lessons, present evidence, and future directions.

Kaewta Jeerapradit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.